Distalmotion

DEXTER robotic surgery system built for outpatient surgical centers

Proof of life. $150M Series G raised Nov 2025 for US expansion

Distalmotion makes DEXTER, a robotic surgery system designed to integrate into existing workflows and bring robotics to ambulatory surgery centers. The system has expanded into benign gynecology indications in the US. A $150M Series G in late 2025 is funding aggressive US expansion.

Category: Medical & Surgical
Headquarters: Lausanne, Switzerland
Country: Switzerland
Founded: 2012
Funding stage: Series G
Total funding: ~$300M+
Website: https://www.distalmotion.com

Investors

Revival Healthcare Capital